Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
2021101 citationsJournal Articlebronze Open Access
Field-Weighted Citation Impact: 6.57
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study | Researchclopedia